[1]Pesi R, Allegrini S, Balestri F, et al. Cytosolic 5'-nucleotidase Ⅱ is a sensor of energy charge and oxidative stress: a possible function as metabolic regulator[J].Cells, 2021,10:182.doi: 10.3390/cells10010182 [2]Goncharova IA, Bragina EY, Zhalsanova IZ, et al. Putative regulatory functions of SNPs associated with bronchial asthma, arterial hypertension and their comorbid phenotype[J]. Vavilovskii Zhurnal Genet Selektsii, 2021,25:855-863. [3]Jiang C, Yang W, Moriyama T, et al. Effects of NT5C2 germline variants on 6-mecaptopurine metabolism in children with acute lymphoblastic leukemia[J].Clin Pharmacol Ther, 2021,109:1538-1545. [4]Duarte RRR, Bachtel ND, Côtel MC, et al. The psychiatric risk gene NT5C2 regulates adenosine monophosphate-activated protein kinase signaling and protein translation in human neural progenitor cells[J].Biol Psychiatry, 2019,86:120-130. [5]Moriyama T, Liu S, Li J, et al. Mechanisms of NT5C2-mediated thiopurine resistance in acute lymphoblastic leukemia[J].Mol Cancer Ther, 2019,18:1887-1895. [6]Johanns M, Kviklyte S, Chuang SJ, et al. Genetic deletion of soluble 5'-nucleotidase Ⅱ reduces body weight gain and insulin resistance induced by a high-fat diet[J].Mol Genet Metab, 2019,126:377-387. [7]Liu H, Sun Y, Zhang X, et al. Integrated analysis of summary statistics to identify pleiotropic genes and pathways for the comorbidity of schizophrenia and cardiometabolic disease[J]. Front Psychiatry, 2020,11:256.doi: 10.3389/fpsyt.2020.00256. [8]Saliba J, Evensen NA, Meyer JA, et al. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia[J].Pediatr Blood Cancer, 2020,67:e28306. doi: 10.1002/pbc.28306 [9]Hunsucker SA, Mitchell BS, Spychala J. The 5'-nucleotidases as regulators of nucleotide and drug metabolism[J].Pharmacol Ther, 2005,107:1-30. [10]Walldén K, Stenmark P, Nyman T, et al. Crystal structure of human cytosolic 5'-nucleotidase Ⅱ: insights into allosteric regulation and substrate recognition[J].J Biol Chem, 2007,282:17828-17836. [11]Mazzon C, Rampazzo C, Scaini MC, et al. Cytosolic and mitochon-drial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy[J].Biochem Pharmacol, 2003,66:471-479. [12]Jeha S, Pei D, Choi J,et al.Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16[J]. J Clin Oncol, 2019,37:3377-3391. [13]Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population[J].Blood, 2020,136:1803-1812. [14]Barz MJ, Hof J, Groeneveld-Krentz S, et al. Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia[J].Blood, 2020,135:921-933. [15]王艳珍,安曦洲,刘江华,等.NT5C2基因在儿童急性白血病中的表达及其临床意义[J].中华血液学杂志,2015,9:748-753. [16]吴遐,郝磊,薛冰,等.NT5C2在急性淋巴细胞白血病中表达水平的观察[J].中华检验医学杂志,2016,39:501-505. [17]Antić , Yu J, Van Reijmersdal SV, et al. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations[J].Haematologica, 2021,106:3046-3055. [18]周海,吴晓玲,林明欣,等.基于网络药理学探讨加味桃核承气汤防治糖尿病肾病的作用机制[J].中国实验方剂学杂志,2019,25:176-186. [19]Singgih EL, van der Voet M, Schimmel-Naber M, et al. Investigating cytosolic 5'-nucleotidase Ⅱ family genes as candidates for neuropsychiatric disorders in drosophila (114/150 chr)[J].Transl Psychiatry, 2021,11:55.doi: 10.1038/s41398-020-01149-x. [20]Xie X, Liu F, Xue Q, et al. Association between NT5C2 rs11191580 and autism spectrum disorder in the Chinese Han population[J].Asian J Psychiatr, 2020,53:102231.doi: 10.1016/j.ajp.2020.102231. [21]Xie X, Liu F, Xue Q, et al. Association between NT5C2 rs11191580 and autism spectrum disorder in the Chinese Han population[J].Asian J Psychiatr, 2020,53:102231.doi: 10.1016/j.ajp.2020.102231. [22]Wang Z, Zhang J, Lu T, et al. Replication of previous GWAS hits suggests the association between rs4307059 near MSNP1AS and autism in a Chinese Han population[J].Prog Neuropsychopharmacol Biol Psychiatry, 2019,92:194-198. [23]Naseer MI, Abdulkareem AA, Pushparaj PN, et al. Exome analysis identified novel homozygous splice site donor alteration in nt5c2 gene in a saudi family associated with spastic diplegia cerebral palsy, developmental delay, and intellectual disability[J]. Front Genet, 2020,11:14.doi: 10.3389/fgene.2020.00014. [24]Chen X, Zhang Z, Wang X, et al. NT5C2 gene polymorphisms and the risk of coronary heart disease[J]. Public Health Genomics, 2020,23:90-99. [25]Vishnolia KK, Hoene C, Tarhbalouti K, et al. Studies in zebrafish demonstrate that CNNM2 and NT5C2 are most likely the causal genes at the blood pressure-associated locus on human chromosome 10q24.32[J]. Front Cardiovasc Med, 2020,7:135. doi: 10.3389/fcvm.2020.00135. [26]Dieck CL, Ferrando A. Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL[J].Blood,2019,133:2263-2268. |